Nearly four years ago, we ran a news story that asked, “Is the neuroscientific study of pain lagging?” From the 2011 story, by Kayt Sukel:
Earlier this year, scientists, politicians and other healthcare advocates came together to share their hopes for the next decade of neuroscience research at the One Mind for Research (OMR) Summit in Boston. At a session highlighting the neurobiological consequences of war, Clifford J. Woolf, a pain researcher at Harvard Medical School and Children’s Hospital Boston, stated, “We have made enormous progress in promoting survival…but, in fact, an area that has really lagged behind relates to the pain associated with combat injury.”
The word that many locked on to in that statement was lagged. In a variety of publications and meetings in the past few years, the idea that the study and treatment of pain, particularly chronic or neuropathic pain, is somehow behind where it should be keeps coming to the surface—and that is whether it’s pain associated with combat, cancer, or some other disease state. But with more than a dozen research journals dedicated solely to the topic of pain and thousands of new pain-related papers being published each year, does a word like lagged accurately reflect the state of its study?